The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
A year ago, Jonathan Montgomery, a 37-year-old firefighter with the Hillsborough County Florida Fire Rescue, was overworked, overweight, and sluggish. “I was strong, but slow and fat,” he said.